This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: Innovations by Inventor Xinghui Sun
Introduction
Xinghui Sun is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment of vascular inflammatory disorders. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Xinghui Sun's latest patents focus on methods of treating vascular inflammatory disorders. One of his patents provides methods for treating or delaying the onset of a vascular inflammatory disease, such as acute lung injury. This involves administering a therapeutically effective amount of a nucleic acid containing all or part of the sequence of mature miR-181b. Additionally, he has developed methods for decreasing nuclear factor-κβ (NF-κβ) signaling in endothelial cells using the same nucleic acid sequence.
Career Highlights
Xinghui Sun is affiliated with Brigham and Women's Hospital, Inc., where he conducts his research. His work is characterized by a commitment to advancing medical treatments and improving patient outcomes.
Collaborations
Some of his notable coworkers include Mark Feinberg and Mark W Feinberg. Their collaborative efforts contribute to the innovative research being conducted at their institution.
Conclusion
Xinghui Sun's contributions to the field of vascular inflammatory disorders through his patents and research at Brigham and Women's Hospital highlight his role as a significant inventor in medical science. His work continues to pave the way for advancements in treatment methodologies.